VA
IRMD icon

Vident Advisory’s iRadimed IRMD Stock Holding History

Vident Advisory’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$949K Buy
+9,856
New +$986K 0.01% 902

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vident Advisory's IRMD Position: Q1 2026 in Review

Vident Advisory opened a new position in iRadimed (IRMD) in Q1 2026: 9,856 shares worth $949K. The stake represents 0.01% of the portfolio and ranks #902 among its holdings.

228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Vident Advisory held 9,856 shares of iRadimed worth $949K as of Q1 2026.
  • iRadimed was a new Vident Advisory position in Q1 2026.
  • iRadimed made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #902 holding.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.